Kurz; Guido

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kurz; Guido.The latest application filed is for "new analogs as androgen receptor and glucocorticoid receptor modulators".

Company Profile

6.19.23

Kurz; Guido - Barcelona ES
KURZ; Guido - Esplugues Llobregat Barcelona
KURZ; Guido - Esplugues Llobregat-Barcelona ES
Kurz; Guido - Madrid N/A ES
Kurz; Guido - Stockholm SE
Kurz; Guido - Langerringen DE
Kurz; Guido - Langerring DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Androgen receptor and glucocorticoid receptor modulators Grant 11,453,660 - Kurz , et al. September 27, 2	2022-09-27
Pyridoquinazoline derivatives useful as protein kinase inhibitors Grant 11,021,479 - Kurz , et al. June 1, 2	2021-06-01
New Analogs As Androgen Receptor And Glucocorticoid Receptor Modulators App 20200325123 - KURZ; Guido ; et al.	2020-10-15
Pyridoquinazoline Derivatives Useful As Protein Kinase Inhibitors App 20200148676 - KURZ; Guido ; et al.	2020-05-14
Carboxylic Acid Derivatives Of Pyridoquinazolines Useful As Protein Kinase Inhibitors App 20200079773 - KURZ; Guido ; et al.	2020-03-12
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 10,329,256 - Ortega Munoz , et al.	2019-06-25
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 10,214,477 - Ortega Munoz , et al. Feb	2019-02-26
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20180354902 - Ortega Munoz; Alberto ; et al.	2018-12-13
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,944,601 - Ortega Munoz , et al. April 17, 2	2018-04-17
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20180079709 - ORTEGA MUNOZ; Alberto ; et al.	2018-03-22
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,670,136 - Ortega Munoz , et al. June 6, 2	2017-06-06
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20170008844 - ORTEGA MUNOZ; Alberto ; et al.	2017-01-12
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20160368857 - ORTEGA MUNOZ; Alberto ; et al.	2016-12-22
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,487,512 - Ortega Munoz , et al. November 8, 2	2016-11-08
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors Grant 9,469,597 - Ortega Munoz , et al. October 18, 2	2016-10-18
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20150119396 - Ortega Munoz; Alberto ; et al.	2015-04-30
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20150025054 - Ortega Munoz; Alberto ; et al.	2015-01-22
(hetero)aryl Cyclopropylamine Compounds As Lsd1 Inhibitors App 20140256729 - Ortega Munoz; Alberto ; et al.	2014-09-11
Imidazo [2, 1-B] [1, 3, 4] thiadiazole derivatives Grant 8,815,918 - Pastor Fernandez , et al. August 26, 2	2014-08-26
Imidazo [2, 1-B] [1, 3, 4] Thiadiazole Derivatives App 20120094996 - Pastor Fernandez; Joaquin ; et al.	2012-04-19
Inhibitors Of 11-beta-hydroxy Steriod Dehydrogenase Type 1 App 20100113435 - BARF; Tjeerd ; et al.	2010-05-06
Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,671,051 - Barf , et al. March 2, 2	2010-03-02
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Grant 7,618,961 - Barf , et al. November 17, 2	2009-11-17
Use of thiazole derivatives and analogues in the treatment of cancer App 20090156644 - Westman; Jacob ; et al.	2009-06-18
Use of thiazole derivatives and analogues in disorders caused by free fatty acids App 20090136472 - Westman; Jacob ; et al.	2009-05-28
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20060287374 - Barf; Tjeerd ; et al.	2006-12-21
Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,132,436 - Kurz , et al. November 7, 2	2006-11-07
Inhibitors of 11-.beta.-hydroxy steroid dehydrogenase type 1 Grant 7,125,900 - Barf , et al. October 24, 2	2006-10-24
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Grant 7,094,792 - Barf , et al. August 22, 2	2006-08-22
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 Grant 7,074,788 - Kurz , et al. July 11, 2	2006-07-11
Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 App 20050250776 - Barf, Tjeerd ; et al.	2005-11-10
New compounds App 20050239853 - Barf, Tjeerd ; et al.	2005-10-27
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20040224996 - Barf, Tjeerd ; et al.	2004-11-11
Method for producing a milling disc and milling disc produced according to the inventive method Grant 6,723,277 - Kurz , et al. April 20, 2	2004-04-20
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20030176476 - Barf, Tjeerd ; et al.	2003-09-18
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20030166689 - Kurz, Guido ; et al.	2003-09-04
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20030130318 - Barf, Tjeerd ; et al.	2003-07-10
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20030130258 - Kurz, Guido ; et al.	2003-07-10
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 App 20030130279 - Kurz, Guido ; et al.	2003-07-10
Sintered friction bearing for motors and gears Grant 6,398,416 - Kurz , et al. June 4, 2	2002-06-04
2-amino-5-pyrimidine acetic acid compounds Grant 6,329,383 - Hedgecock , et al. December 11, 2	2001-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.